Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Single-nucleotide polymorphisms: a perspective of cardiovascular prevention.

Revista da Associacao Medica Brasileira (1992) - 1 Jan 2000

Grezzana Guilherme Brasil, Vieira José Luiz da Costa, Portal Vera Lúcia

Abstract excerpt

INTRODUCTION: several studies have evaluated the utilization of lipid biomarkers in an attempt to correlate them with clinical cardiovascular events. Nevertheless, the investigation of clinical conditions under specific plasmatic levels of lipoproteins for long periods presents limitations due to inherent difficulties that are related to the follow-up of individuals throughout their lives. Better understanding of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Cholesterol, LDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dyslipidemias

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Lipid Metabolism

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 26603010
DOI: 10.1590/1806-9282.61.05.458

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Single-nucleotide polymorphisms: a perspective of cardiovascular prevention.PMID 26603010Read ↗

Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease.Semantic proximity Read ↗

Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.Semantic proximity Read ↗

Association between selected gene polymorphisms and statin metabolism, risk of ischemic stroke and cardiovascular disorders.Semantic proximity Read ↗

The Potential of Single Nucleotide Polymorphisms (SNPs) as Biomarkers and Their Association with the Increased Risk of Coronary Heart Disease: A Systematic Review.Semantic proximity Read ↗

Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.Semantic proximity Read ↗

Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).Semantic proximity Read ↗

Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Cardiovascular Diseases: A Literature ReviewSemantic proximity Read ↗

Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention.Semantic proximity Read ↗

When the same treatment has different response: The role of pharmacogenomics in statin therapySemantic proximity Read ↗

Clinical Lipidology and the Prevention of Vascular Disease: Time for Personalized Therapy.Semantic proximity Read ↗

Genetic determinants of response to statins.Semantic proximity Read ↗

Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.